Key Questions: HIV and COVID-19

May 28, 2021 | Julia Zigman

Just as the COVID-19 pandemic hit the United States (U.S.), the nation was ramping up efforts to address a different epidemic, HIV. Successful HIV outcomes require consistent access to care and medication, as does harnessing the preventive benefits of HIV treatment adherence. Similarly, key tools in HIV prevention are HIV testing and PrEP which necessitate access to health services. Yet, with options for medical care reduced, social distancing guidelines in place, and fears about COVID-19 exposure, COVID-19 threatened access to HIV care and prevention services and national efforts to address HIV. In addition, understanding the interplay of COVID-19 disease, vaccination, and HIV is important to the health of people with and at risk for HIV and curbing both epidemics. This analysis explores key questions around COVID-19 and HIV – what we know and what we are still learning.

Key questions addressed in this analysis:

  • Are people with HIV at higher risk for COVID-19?
  • How do the social determinants of health, and their relationship to HIV, affect COVID-19 risk?
  • How likely is it that people with HIV live in COVID-19 hot spots?
  • What do we know about COVID-19 vaccines and HIV?
  • What role is the federal government playing in addressing COVID-19 among people with HIV?
  • What do we know about HIV care, treatment, and prevention service use during the pandemic?

Continue reading “Key Questions: HIV and COVID-19” by Lindsey Dawson and Jennifer Kates at KFF.org.


NACCHO logo small version02 square N pms321 Invert

About Julia Zigman

Pronouns: she/her

Julia Zigman is a Program Analyst on the NACCHO HIV, STI, & Viral Hepatitis team. Julia focuses primarily on NACCHO’s Ending the HIV Epidemic portfolio and is a lead staff member for the HIV, STI, and Viral Hepatitis Workgroup. Learn more about these programs here.

More posts by Julia Zigman

Related Posts

HIV COVID
  • COVID-19
  • HIV, STI, & Viral Hepatitis

COVID-19: Considerations for People with HIV

Updated resource discussing clinical and public health considerations related...

Jan 06, 2021 | Julia Zigman

COVID-19: Considerations for People with HIV

HIV COVID
  • COVID-19
  • HIV, STI, & Viral Hepatitis

Study: Poorer COVID-19 Outcomes Among Persons Living...

Persons living with an HIV diagnosis experienced poorer COVID-related outcomes...

Feb 04, 2021 | Julia Zigman

Study: Poorer COVID-19 Outcomes Among Persons Living...

HIV COVID
  • COVID-19
  • HIV, STI, & Viral Hepatitis

HIV Included in CDC Vaccine Prioritization for COVID-19

HIV is now included among CDC’s list of medical conditions that can increase...

Apr 01, 2021 | Julia Zigman

HIV Included in CDC Vaccine Prioritization for COVID-19

HIV COVID
  • COVID-19
  • HIV, STI, & Viral Hepatitis

When Epidemics Collide: Why People with HIV May Have...

An article published in Clinical Infectious Diseases in January 2021...

Jan 06, 2021 | Julia Zigman

When Epidemics Collide: Why People with HIV May Have...

  • COVID-19
  • HIV, STI, & Viral Hepatitis

Video: American Academy of HIV Medicine’s Academy...

This video from the AAHIVM’s Academy Council for Racial Equity features Black...

May 13, 2021 | Shalesha Majors

Video: American Academy of HIV Medicine’s Academy...

Back to Top